Page 23 - LG Cancro endometrio

of Clinical Oncology, Beatson Oncology Centre, Gartnavel General Hospital, Glasgow, UK;
A. Rodolakis, First Department of Obstetrics and Gynecology, Athens University, Alexandra Hospital,
Athens, Greece; H. Salvesen, Department of Clinical Science, Haukeland University Hospital,
Bergen, Norway; J. Sehouli, Department of Gynecology, Charité– Universitätsmedizin Berlin, Berlin,
Germany; C. Sessa, Department of Medical Oncology, Oncology Institute of Southern Switzerland,
Ospedale San Giovanni, Bellinzona, Switzerland; A. Taylor, Gynaecology Unit and Department of
Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK; A. Westermann, Department
of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands; A. G. Zeimet,
Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria.

Access the full ESGO Guidelines

© 2018 European Society of Gynaecological Oncology
All rights reserved. No part of this book can be reprinted, reproduced, transmitted or utilised
in any form by any electronic, mechanical, or other means, now known or hereafter invented,
including photocopying, microfilming, and recording, or any information storage or retrieval
system, without written permissions of ESGO.
Reasonable efforts have been made to publish reliable data and information, but the authors and
publisher cannot assume responsibility for the validity of all materials or for the consequences of
their use, and the ultimate responsibility rests with the prescribing physician.

23